25 Results for "

MDMX

" in MedChemExpress (MCE) Product Catalog:
Products (25)

25 Results for "MDMX" in MCE Product Catalog:

2
2 Cited Publications
Referencia número: HY-P4210
No. CAS: 1451199-98-6
Synonyms: ALRN-6924; MP-4897
Target:  

MDM-2/p53

Áreas de investigación:  

Cancer

Sulanemadlin (ALRN-6924) is a potent and cell-permeating p53-based peptidomimetic macrocycles. Sulanemadlin is a inhibitor of the p53-MDM2, p53-MDMX, or both p53 and MDM2 and MDMX protein-protein interactions. Sulanemadlin can be used for cancers research .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-108638
No. CAS: 59474-01-0
Pureza:  99.60%
Synonyms: XI-011 hydrochloride
Target:  

MDM-2/p53 Apoptosis PARP

Áreas de investigación:  

Cancer

NSC 146109 hydrochloride (XI-011 hydrochloride) is a p53 activator and MDMX inhibitor. NSC 146109 hydrochloride inhibits MDMX gene transcription, downregulates MDMX mRNA and protein levels, stabilizes p53 and activates the transcriptional activity of p53. NSC 146109 hydrochloride induces cancer cell apoptosis (apoptosis) and inhibits the growth of transformed cells. NSC 146109 hydrochloride inhibits the growth of xenograft tumors. NSC 146109 hydrochloride can be used in research related to breast cancer and cervical cancer .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-16664
No. CAS: 431979-47-4
Áreas de investigación:  

Cancer

SJ-172550 is a small molecule inhibitor of MDMX; competes for the wild type p53 peptide binding to MDMX with an EC50 of 5 μM.
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-14714
No. CAS: 58131-57-0
Pureza:  98.85%
Synonyms: XI-006
Target:  

MDM-2/p53

Áreas de investigación:  

Cancer

NSC-207895 (XI-006), a DNA damaging agent, is an anticancer agent and p53 activator .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-120086
No. CAS: 1416663-77-8
Pureza:  99.97%
Áreas de investigación:  

Cancer

RO-5963 is a dual p53-MDM2 and p53-MDMX inhibitor with IC50s of ~17 nM and ~24 nM, respectively .
loading...
    loading...
Referencia número: HY-141584
No. CAS: 1451197-99-1
Target:  

MDM-2/p53

Áreas de investigación:  

Cancer

ATSP-7041, a selective dual peptide inhibitor of MDM2 and MDMX, effectively reactivates the p53 tumor suppressor pathway in a mechanism-dependent manner in p53-positive cancers .
loading...
    loading...
Referencia número: HY-123950
No. CAS: 430458-66-5
Pureza:  ≥98.0%
Target:  

MDM-2/p53 Apoptosis

Áreas de investigación:  

Cancer

MMRi64 disrupts Mdm2-MdmX interactions. MMRi64 downregulates Mdm2 and MdmX in leukemia cells. MMRi64 induces p53 accumulation, and induces the apoptotic arm of the p53 pathway in leukemia/lymphoma cells. MMRi64 can be used for cancer research .
loading...
    loading...
Referencia número: HY-148106
No. CAS: 642072-49-9
Target:  

Ligands for E3 Ligase

Áreas de investigación:  

Cancer

MEL23 is a MDM2 E3 ligase inhibitor that blocks the E3 ligase activity of the MDM2-MDMX complex. MEL23 inhibits Mdm2 and p53 ubiquitination in cells, reduce viability of cells with wild-type p53. MEL23 stabilizes MDM2 via a mechanism independent of p53 transcription .
loading...
    loading...
Referencia número: HY-149250
No. CAS: 3043723-74-3
Target:  

MDM-2/p53 Apoptosis

Áreas de investigación:  

Cancer

MDMX/MDM2-IN-2 is a potent p53-MDM2/MDMX dual inhibitors with Kis of 0.23 μM and 2.45 μM for MDM2 and MDMX, respectively. MDMX/MDM2-IN-2 inhibits the binding of p53 and MDM2 proteins. MDMX/MDM2-IN-2 restores the function of p53 and enables cell cycle arrest and apoptosis. MDMX/MDM2-IN-2 inhibits cell migration and invasion. MDMX/MDM2-IN-2 has antitumor activity .
loading...
    loading...
Referencia número: HY-124791
No. CAS: 709009-15-4
Target:  

MDM-2/p53 PARP

Áreas de investigación:  

Cancer

MMRi6 is a Mdm2-MdmX RING domain inhibitor that can disrupt Mdm2-MdmX RING-RING interaction in vitro. MMRi6 inhibits MdmX-stimulated Mdm2 autoubiquitination and Mdm2-MdmX-mediated p53 polyubiquitination in vitro without affecting NEDD4-1 autoubiquitination. MMRi6 induces p53 stabilization and accumulation and induces PARP cleavage in wt-p53 Emu-myc lymphoma cells. MMRi6 inhibits the growth of wt-p53 and p53-null Emu-myc lymphoma cells with IC50s of approximately 0.5 μM and 3 μM, respectively. MMRi6 can be used for the study of leukemia/lymphoma .
loading...
    loading...
Referencia número: HY-P11256
No. CAS: 1443628-44-1
Target:  

MDM-2/p53

Áreas de investigación:  

Cancer

pDI is a peptide. pDI inhibits MDM2-p53 and MDMX-p53 interactions with IC50s of 10 and 100 nM respectively. pDI can be used in the research of colorectal cancer .
loading...
    loading...
Referencia número: HY-P11255
Target:  

MDM-2/p53

Áreas de investigación:  

Cancer

SPDI-48-T1 is a lysine-stapled peptide. SPDI-48-T1 exhibits discernible binding affinities for MDM2 and MDMX, with Kd values of 396 nM and 456 nM, respectively. SPDI-48-T1 exhibits anticancer activity against breast cancer, colorectal cancer, non-small cell lung cancer, cervical cancer, and malignant melanoma .
loading...
    loading...
Referencia número: HY-107466
No. CAS: 1067654-70-9
Target:  

MDM-2/p53

Áreas de investigación:  

Cancer

WK298 is a potent inhibitor of the MDM2/MDMX-p53 interaction with good anti-tumor activity. WK298 can fully activate the p53 pathway by inhibiting the binding of MDM2 and MDMX to p53. The development of WK298 benefited from a deep understanding of the key elements of the p53-MDM2/MDMX interaction structure .
loading...
    loading...
Referencia número: HY-RS16923
Áreas de investigación:  

Others

Mdm4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mdm4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-P10286
No. CAS: 186180-20-1
Target:  

MDM-2/p53

Áreas de investigación:  

Cancer

Phage-derived 12/1 peptide exhibits antitumor activity by targeting MDM2 and MDMX, an thus disrupt the MDM2-p53 and MDMX-p53 interaction, with IC50 of 0.15 and 1.25 μM .
loading...
    loading...
Referencia número: HY-164550
No. CAS: 2247210-09-7
Target:  

HDAC

Áreas de investigación:  

Cancer

YF438 is an HDAC inhibitor with effective anticancer activity both in vitro and in vivo. YF438 inhibits the growth and metastasis of triple-negative breast cancer (TNBC) cells by blocking the interaction between HDAC and MDM2, inducing the dissociation of MDM2-MDMX, and promoting the degradation of MDM2 .
loading...
    loading...
Referencia número: HY-RS08267
Áreas de investigación:  

Others

MDM4 Human Pre-designed siRNA Set A contains three designed siRNAs for MDM4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-163275
Target:  

MDM-2/p53 Apoptosis

Áreas de investigación:  

Cancer

MDM2-IN-24 (compound A3f) exhibits MDM2-inhibiting and MDMX-activating properties in triple-negative breast cancer (TNBC) cells, with apoptotic and anti-proliferative activities .
loading...
    loading...
Referencia número: HY-P74756
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Protein Mdm4; Protein MDMX; MDM4; MDMX
Species:  
Source:  
loading...
    loading...
Referencia número: HY-P85272
Synonyms: MDM4; MDMX; Protein Mdm4; Double minute 4 protein; Mdm2-like p53-binding protein; Protein MDMX; p53-binding protein Mdm4

Host:  

Mouse

Application:  

WB, IHC-P, FC, ELISA

Reactivity:  

Human

loading...
    loading...